Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$19,074,107,484
+$4,705,632,541 QoQ
Shares Held
15,902,642
+1.8% QoQ
Ownership
1.69%
of shares outstanding
% of Portfolio
2.26%
of 13F equity value
Holder Rank
#11
of 4,587 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital World Investors holds $50,250,725,849 across 10 Drug Manufacturers - General names. LLY ranks #1 (38.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
15,902,642 | $19,074,107,484 | |
| 2 | AMGN |
Amgen Inc
|
29,075,329 | $10,528,758,137 | |
| 3 | AZN |
Astrazeneca PLC
|
30,075,134 | $5,702,846,909 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
40,988,975 | $5,178,547,101 | |
| 5 | ABBV |
AbbVie Inc.
|
19,178,966 | $4,826,195,004 | |
| 6 | JNJ |
Johnson & Johnson
|
15,215,015 | $3,864,157,359 | |
| 7 | PFE |
Pfizer Inc
|
22,218,190 | $535,014,015 | |
| 8 | NVO |
Novo Nordisk A S
|
5,205,926 | $249,572,092 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,074,107,484 | 15,902,642 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $14,368,474,943 | 15,621,813 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $16,154,322,593 | 15,031,750 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $11,422,032,937 | 14,969,899 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $13,746,615,548 | 17,634,492 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $15,182,350,866 | 18,382,573 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $15,094,535,404 | 19,552,507 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $18,034,146,799 | 20,355,946 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $19,749,744,744 | 21,813,763 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $19,088,069,347 | 24,536,055 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $15,709,561,677 | 26,949,773 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $14,427,340,267 | 26,860,053 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $12,600,358,137 | 26,867,581 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $9,474,456,406 | 27,588,540 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $10,312,458,523 | 28,188,439 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $9,385,193,007 | 29,024,874 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $9,319,228,112 | 28,742,646 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $6,402,787,608 | 22,358,444 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $5,280,192,793 | 19,115,896 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,879,417,761 | 16,790,382 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,508,906,120 | 15,288,019 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,728,352,347 | 14,604,177 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $481,861,086 | 2,853,951 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $455,660,179 | 3,078,369 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $505,333,562 | 3,077,924 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $420,994,253 | 3,034,849 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||